Aldo Peixoto, MD

Aldo Peixoto, MD
Accepting new patients? Yes
Referrals required? From patients or physicians
Patient type treated: Adult; Older Adult
Board Certified in Internal Medicine and Nephrology

Aldo Peixoto, MD, is the chief of nephrology at Yale Medicine. He specializes in resistant and secondary forms of hypertension, cardiovascular dysautonomia (an autonomic nervous system disorder) and in general consultative nephrology and hypertension.

Dr. Peixoto received his medical degree from the Federal University of Santa Catarina in Brazil in 1992. He was a medical resident and chief medical resident at the University of Connecticut Health Center from 1992 to 1996 and later completed a nephrology fellowship at Yale University. In 1998, he joined Yale Medicine as a full-time faculty member.

As a clinician, Dr. Peixoto believes in letting his patients share in the decision-making process. “It’s not about what I want the patient to do. It’s about what the two of us can agree on that is important for the patient and then moving forward as a team,” he says. In order to accomplish this, Dr. Peixoto tries to understand patients’ preferences early on—whether it’s certain types of medication or if their lifestyle prevents them from accessing certain treatments. This type of information is particularly important in diseases where there is not enough scientific research to make a strong recommendation and there is some flexibility in treatment options, says Dr. Peixoto.

In addition to seeing patients, Dr. Peixoto conducts research on how blood pressure, the vascular system, and kidney disease affect each other. At the Yale School of Medicine, he is a professor of medicine (nephrology).   

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.